Journal article
Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among US Adults: Updated Recommendations of the Advisory Committee on Immunization Practices-United States, 2022
MMWR. Morbidity and mortality weekly report, v 71(4), pp 109-117
28 Jan 2022
PMID: 35085226
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
What is already known about this topic?
Currently, the 13-valent pneumococcal conjugate vaccine (PCV) (PCV13) and the 23-valent pneumococcal polysaccharide vaccine (PPSV23) are recommended for U.S. adults. Recommendations vary by age and risk groups.
What is added by this report?
On October 20, 2021, the Advisory Committee on Immunization Practices recommended 15-valent PCV (PCV15) or 20-valent PCV (PCV20) for PCV-naive adults who are either aged >= 65 years or aged 19-64 years with certain underlying conditions. When PCV15 is used, it should be followed by a dose of PPSV23, typically >= 1 year later.
What are the implications for public health practice?
Pneumococcal vaccination recommendations were simplified across age and risk group. Eligible adults may receive either PCV15 in series with PPSV23 or PCV20 alone.
Metrics
Details
- Title
- Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among US Adults: Updated Recommendations of the Advisory Committee on Immunization Practices-United States, 2022
- Creators
- Miwako Kobayashi - CDC, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USAJennifer L. Farrar - CDC, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USARyan Gierke - CDC, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USAAmadea Britton - CDC, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USALana Childs - CDC Fdn, Atlanta, GA USAAndrew J. Leidner - CDC, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USADoug Campos-Outcalt - University of ArizonaRebecca L. Morgan - McMaster UniversitySarah S. Long - Drexel UniversityH. Keipp Talbot - Vanderbilt UniversityKatherine A. Poehling - Supreme Council Of HealthTamara Pilishvili - CDC, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA
- Publication Details
- MMWR. Morbidity and mortality weekly report, v 71(4), pp 109-117
- Publisher
- Centers Disease Control & Prevention
- Number of pages
- 9
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Pediatrics
- Web of Science ID
- WOS:000748400300001
- Scopus ID
- 2-s2.0-85123905675
- Other Identifier
- 991019335228104721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
Highly Cited Paper
- Collaboration types
- Domestic collaboration
- International collaboration
- Web of Science research areas
- Public, Environmental & Occupational Health